Background: This study aimed to quantify the prevalence of chronic kidney disease (CKD) and associated metabolic risk factors in a middle-aged and elderly population in Guishan District, Taoyuan City, Taiwan.
CKD is 11.93% in adults of all ages (age ≥ 20 years) in Taiwan [2] . Treatments for CKD have the greatest effects on slowing the rate of disease progression when started early.
CKD can be divided into five stages based on the appearance of kidney damage or estimated glomerular filtration rate (eGFR) < 60 mL/min/1.73 m 2 . Unfortunately, most patients are unaware of their disorder until they are in the later stages [2] .
Metabolic syndrome is another global health concern with rising prevalence. It is defined as a cluster of disorders and risk factors for cardiovascular disease (CVD), including abdominal obesity, hyperglycemia (including impaired glucose tolerance and diagnosed diabetes), dyslipidemia, and elevated blood pressure. Prospective observational studies demonstrate a strong association between the metabolic syndrome and risk for subsequent development of type 2 diabetes [3] [4] [5] [6] , CVD [7] [8] [9] [10] , hyperuricemia, gout [11, 12] , and CKD [13] . These factors interact as both cause and effect, and the multiple mechanisms involved in the development of CKD in patients with metabolic syndrome have not been well established.
The purpose of the present study is to quantify the prevalence of CKD and associated risk factors, especially metabolic syndrome, in a middle-aged and elderly population in Taiwan.
Understanding prevalence of CKD and important risk factors may lead to early detection of CKD and prevention of end-stage renal disease (ESRD), CVD, and reduce associated mortality.
Methods

Study design and subjects
This community based, cross-sectional study enrolled 400 volunteer residents aged 50 and over who lived in Guishan District, Taoyuan City, Taiwan, between January 2014 and October 2014. We recruited these volunteer subjects to join our study at gathering places in town such as temples and community centers. Each participant received a standardized personal interview, including structured questionnaire, anthropometric measurements, and collection of blood samples, on a single day.
Data collection
Data were collected from participants by structured questionnaire, including smoking habits, physical exercise habits, medical history, and current medications. Height and weight were measured to the nearest 0.1 kg and 0.1 cm using an automatic scale. BMI was calculated as the ratio between weight and height in meters squared (kg/m 2 ). Waist circumference was measured at the mid-point between the lower border of the rib cage and the upper iliac crest on the mid-axillary line. Blood pressure was determined using an automatic sphygmomanometer on the right upper arm after at least 15 minutes of rest.
Venous blood samples were collected after overnight fasting for at least 12 hours. All blood samples were stored in a refrigerator at 4 °C and then analyzed at the clinical laboratory of Linkou Chang Gung Memorial Hospital, which was certified by the College of American Pathologists. Urine specimens were obtained in the morning, and scheduled to avoid menstrual periods. The study protocol was approved by the institutional review board (IRB) of the study hospital and signed informed consent was provided by all participants before enrollment. 
Definitions of measurement cutoffs and calculations
Statistical analysis
Data are presented as mean ± SD (standard deviation) for continuous variables and number of subjects (%) for categorical variables. Differences in the mean values of continuous variables were examined using the independent t-test and one-way ANOVA, while 2-trend test was used for differences in proportions between categorical variables.
Mantel-Haenszel 2 test was used to analyze stratified categorical data. Multiple logistic regression models were developed to investigate the independence of risk factors associated with CKD. All statistical analyses were performed using SPSS for Windows, SPSS version 19.0 (SPSS Inc., Chicago, IL). A probability value of less than 0.05 was considered to be significant.
Results
As shown in Fig. 1 , the overall prevalence of CKD in the study population (age ≥ 50 years) was 20.3% (95% CI: 16.36%-24.24%). The prevalence of CKD increased with age (p value for Cochran-Armitage trend test = 0.022), and more than one in three participants older than 75 years old (prevalence: 33.9%, 95% CI:21.50%-46.30%) were diagnosed to have CKD in this community-based study.
A total of 400 participants were categorized into 3 different age groups: 50-64 years old (n = 232), 65-74 years old (n = 112), and age 75 and ≥ 75 years (n = 56). The ratio of waist circumference to height (WC/height), diastolic blood pressure (DBP), total cholesterol, alanine aminotransferase (ALT), creatinine and eGFR were significantly different between the age subgroups ( Table 1 ). We also compared demographic, anthropometric and clinical characteristics between CKD and non-CKD groups and found that age, waist circumference, ratio of waist circumference to height, systolic blood pressure (SBP), DBP, fasting glucose, triglycerides (TG), high-density lipoprotein cholesterol (HDL-C), ratio of TG to HDL, and uric acid were the factors significantly associated with CKD (Table 1) . Table 1 Demographic, anthropometric and biochemical characteristics of screened subjects with and without chronic kidney disease (n = 400).
Age
Chronic kidney disease Table 2 shows the associations between the five components of metabolic syndrome and CKD. Elevated blood pressure, hyperglycemia, hypertriglyceridemia, and low HDL-C were statistically significantly associated with an increased age-specific prevalence of CKD, while central obesity showed a similar trend but without statistical significance. 
Discussion
In our study, hypertension, hyperglycemia, hyperuricemia and metabolic syndrome are significantly associated with CKD in a middle-aged and elderly population in Taiwan.
In several studies among different countries and races, the metabolic syndrome has been disclosed as a risk factor for developing CKD [16] [17] [18] [19] [20] . In Japan, Tozawa et al followed 6,371 subjects without CKD or diabetes mellitus for a 5-year period and found that the relative risk of developing CKD was 1.86 (95% CI: 1.43-2.41, p < 0.0001) in subjects with metabolic syndrome after adjusting for age, sex, current cigarette smoking and alcohol drinking habits [21] . In the United States, Kurella et al enrolled 10,096 nondiabetic participants with 9 years follow-up, also revealing that metabolic syndrome was independently associated with an increased risk for incident CKD in nondiabetic adults;
the OR of incident CKD among participants with the metabolic syndrome was 1.24 (95% CI, 1.01 to 1.51) after adjusting for the subsequent development of diabetes and hypertension [22] . In the present study, metabolic syndrome also serves as an independent risk factor for the development of CKD (yes versus no, OR = 2.48, 95% CI:
1.40-4.40) in a middle-aged and elderly population in Taiwan after adjusting for age, sex, smoking, physical exercise, BMI categories, ALT, and uric acid.
Each component of metabolic syndrome can cause renal damage; however, the components may not contribute equally to the risk of developing CKD [17, 23, 24] . Many studies have further reported the gradient associations between CKD risk and the number of components of metabolic syndrome [21, 22, [24] [25] [26] . The multiple mechanisms of renal damage caused by each metabolic syndrome component and their interactions with each other are not yet thoroughly understood. In the present study, elevated blood pressure and hyperglycemia served as independent risk factors for CKD, while other components did not reach statistical significance after adjusting for confounding factors.
High-normal BP is significantly associated with microalbuminuria when compared with optimal BP, and the increase in urinary protein causes injury to tubular cells, leading to interstitial inflammation and fibrosis [27, 28] . Previous studies have also revealed that elevated blood pressure, as a component of metabolic syndrome, is an independent risk factor for the development of CKD. Cao et al. [29] enrolled 11274 subjects and found CKD risk was significantly greater (OR, 1.30; 95% CI: 1.03-1.63) in males with high-normal blood pressure than in those with optimal blood pressure. Song et al. [24] followed 75,468 urban workers for a 2-year period and found that the OR of metabolic syndrome related to reduced eGFR was 1.43 (95% CI, 1.13 to 1.83) [24] . In addition, lower blood pressure targets (i.e., 130/80 mmHg) are strongly associated with better renal outcomes [30] . Thus, aggressive blood pressure control is suggested in the management of patients with metabolic syndrome and mild renal function decline to promote a better prognosis.
Hyperglycemia, including previously diagnosed diabetes and impaired fasting glucose, is another component of metabolic syndrome that is significantly associated with CKD in the present study. Increased GFR, also called hyperfiltration, is a proposed mechanism for renal injury in diabetes, which has been hypothesized to cause intra-glomerular hypertension leading to albuminuria and then reduced GFR. Hyperfiltration also occurred in patients with impaired fasting glucose, and can be used as a predictor of diabetic nephropathy [31] [32] [33] [34] .
Hypertriglyceridemia, low HDL-C levels, and central obesity were not significantly associated with CKD in the present study. Several other studies also had similar results.
Although metabolic syndrome itself is an independent risk factor associated with CKD, dyslipidemia (including both hypertriglyceridemia and low HDL-C level) is not significantly associated with the development of CKD [18, 21, 22, 25, 26, 35] . Some studies have shown that hypertriglyceridemia or low HDL-C level is only significantly associated with the development of CKD in patients with metabolic syndrome [24, 36] . However, the role of central obesity in developing CKD has not reached consensus [25, 27, [36] [37] [38] .
Differences in race, large disparities in subjects' ages, definition of CKD, and adjusted confounding factors in these studies might be other reasons for discrepancies between studies.
The present study has several limitations. First, this was a cross-sectional study, thus, the causal relationship between CKD and associated risk factors cannot be evaluated and determined. Second, the number of participants in this study was relatively small and all were recruited from only a single community. Third, volunteer bias may exist due to subjects participating on a volunteer basis. Volunteer bias is defined as the bias that comes from the fact that a particular sample contains only those participants who are actually willing to participate in the study. Those who participate and find the topic particularly interesting are more likely to volunteer, and the same is true of those who are expected to be evaluated on a positive level [39] . In addition, we recruited these volunteer subjects to join our study at gathering places in town such as temples and community centers. This means that people who require considerable assistance or frequent medical care had a lower possibility to be recruited. Volunteer bias would potentially influence the prevalence of CKD and the associated risk factors, and the association between CKD and associated risk factors in those who require substantial assistance or care might not be observed in the present study.
Conclusions
CKD is significantly associated with older age, elevated uric acid level, and metabolic syndrome after adjusting for sex, smoking, physical exercise, ALT, and BMI categories in a middle-aged and elderly population in Taiwan. Among the components of metabolic syndrome, elevated blood pressure and hyperglycemia are independently associated with the risk of CKD. For patients with metabolic syndrome, clinical intervention such as life style modification, weight reduction, the use of medications to correct elevated blood pressure, hyperglycemia, dyslipidemia, and hyperuricemia should be provided to prevent or delay the progression of CKD.
Abbreviations CKD, chronic kidney disease; CVD, cardiovascular disease; BMI, body mass index; WC, waist circumference; SBP, systolic blood pressure; DBP, diastolic blood pressure; FPG, fasting plasma glucose; HDL-C, high-density lipoprotein cholesterol; TG, triglyceride; ALT, alanine aminotransferase; HS-CRP, high sensitivity C-reactive protein; eGFR, estimated glomerular filtration rate; CI, confidence interval. Figure 1 Age-specific prevalence of chronic kidney disease in screened subjects in Guishan District, Taoyuan City, Taiwan (n=400).
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